Ir al contenido principal

Smoke and Alzheimer´s disease.

Everybody have two or three friends who are smoking. Also, we have sadly some familiar who suffers Alzheimer or anything similar dementia. I ask myself, what kind of relation is there between smoke and the Alzheimer? This week I have read an article through to Mind and Brain´s (Mind & Brain) magazine and I have found what it could have a direct relation.

People know that Alzheimer's disease has an aetiology unknown because the main researches didn´t find any reason. Despite it being unknown, we can know that is more often find it in woman who is 65 or more age, and it coexists with other pathologies like diabetes and cardiovascular disease. Also, there are other behaviour mental and physical that can benefit or harm the occurrence of the Alzheimer. Once of this is the smoke.


At the beginning people thought what if you smoked, you would be protected of the many illness like Alzheimer. The main researches didn´t found any direct relation between appearance of this dementia, and the behaviour to smoke. However, researches didn´t consider many factors like other causes associated with smoking. Here, we can say, that didn´t regard illness like cancer or CVD. Neither In the laboratory, the researches didn´t find a relation with the main hypothesis. In fact, research with transgenic mice suggested that the treatment with nicotine, could show an improvement in the development of this dementia.

In order to we want to understand better this idea, I should show you a biological explanation. In first time, there are in the mice´s brain a group of neurons with nicotinic Ach receptors. Those, are activated by nicotine when this is in theirs brain. Second, these receptors affect to the memory and attention processes too. Therefore, the researches managed nicotine to the mice. The thought that if they managed nicotine these animals, then they would have Alzheimer in the future. Results showed an improvement in their cognitive processes also an increased neuronal survival. Surely, these people didn´t attended other factors and components which we can find in a cigarette, like carbon monoxide, tar, hydrogen cyanide and ammonia.

After that, the researches wanted to check if there was a relation between the behaviours smoking with the Early-onset of Alzheimer. Workers did a procedure more applicable to human life. They chose mice that were old and with high probability to suffer Alzheimer. Also, these mice must have a genetic predisposition for this dementia. Claudio Soto was the director of this research, which were doing for 4 months. The researches exposed to mice smoke snuff daily. That smoke, was inhaled by a box. The cigarette had to be fired for one hour and a bomb sucked out the smoke, and this was introduced in the box again. Thus, these people were able to do a situation where a person smokes 3-4 cigarettes daily. Also, the workers did a control group to see the contrast with the experimental group. This control group didn´t breath the smoke snuff.


Results showed in the experimental group if we compare to the control group more amount of toxic proteins in the brain. Also they saw the brain regions relation with memory and learning were inflamed. They concluded that behaviour smoking can high the probability to suffer Alzheimer´s disease, that this appear early, and worsen their symptoms. Besides, if we had to put these results to the humans, we could say that an active smoke has twice as likely to suffer this dementia.

Sadly, there aren´t more discoveries about this disease. Nobody knows what is the main reason of the appear to Alzheimer neither nobody knows what is the molecular mechanics by the behaviour smoke high the probability to suffer Alzheimer´s disease.

Bibliography:
Moreno González, Inés. Tabaco y demencia. Mente y Cerebro. January / February 2014 Nº 64  p. 60-61.


Comentarios

Entradas populares de este blog

Verdaderas y falsas ventajas del Mini Mental State Examination (MMSE)

Introducción  Todo aquel que esté familiarizado con el ámbito de la psicología, la neurología, la psiquiatría o las neurociencias, sabrá de la existencia de un test de screening llamado Mini Mental State Examination . Pero, ¿qué es este test? ¿Qué es eso de " Screening" ?  Para empezar, el Mini Mental State Examination es un Test Cognitivo Breve (o de Screening , como he mencionado antes), que es de uso habitual para la detección y cribado de deterioro cognitivo o demencia. Su principal característica reside en la exploración de forma rápida (de entre 5-10 minutos), de cara a detectar signos de deterioro o alteración cognitiva  que debe ser examinada mediante una evaluación más exhaustiva. Es decir, el uso de este tipo de test es de comprobar si hay algo que va mal. No obstante, nunca podrán aportar datos esclarecedores que pueda justificar la emisión de un diagnóstico, a pesar de ser un Test Multidominio (que evalúa numerosas funciones cognitivas).  Venta

Neuropsicología de la demencia frontotemporal

Introducción La demencia frontotemporal es un tipo de demencia que se caracteriza por un trastorno de conducta que suele manifestarse antes de los 65 años que destaca sobre un deterioro cognitivo que también es notorio (González & Fernández, 2005). Es responsable del 20% de las muertes y es la segunda causa de muerte por demencia presenil (Turro et al, 2015). A nivel cerebral se asocia con una atrofia de la parte anterior de los lóbulos temporales y frontales, siendo responsables de una sintomatología que la diferencia de otros tipos de demencias como la Enfermedad de Alzheimer, Cuerpos de Lewy o la Enfermedad de Parkinson (Ostrosky & Lozano, 2012). Por otra parte, la comorbilidad con otras enfermedades como la Enfermedad de la Motoneurona ( Esclerosis Lateral Amiotrófica ), reduce aún más la esperanza de vida, situándose en una media de 3 años de supervivencia. Variantes de Demencia Frontotemporal La demencia frontotemporal engloba al menos tres subtipos

¿Cuáles son los factores de riesgo de padecer Demencia?

Antes de comenzar explicando cuales son los diferentes factores determinantes que pondrían en población de riesgo de padecer demencia a una persona, vamos a describir lo que los estudios epidemiológicos entienden por “ riesgo ”. Entendemos por esta palabra, un concepto que describe una futura probabilidad de padecer una enfermedad en función de una exposición a un acontecimiento o sustancia en general, a nivel de población. De esta forma, decimos que dicha exposición puede incrementar o disminuir la probabilidad de padecer una alteración (Hughes and Ganguli, 2009). Como señalan numerosas investigaciones, la patología de la demencia a nivel cerebral empieza a desarrollarse varios años antes de la aparición de los signos y síntomas característicos. Por ello los estudios epidemiológicos de las demencias deben de centrarse en las etapas más tempranas de la vida, para así poder evaluar los diferentes y numerosos factores de riesgo que pueden ser modificables. Identificar dichos factor